FDA
approval
· 2024-02-16
FDA Approved: NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL — Supplemental Application (Nivagen Pharmaceuticals, Inc.)
Summary
The FDA approved a supplemental application for norethindrone acetate and ethinyl estradiol from Nivagen Pharmaceuticals, a combined oral contraceptive.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL (NORETHINDRONE ACETATE AND ETHINYL ESTRADIOL)